Efficacy and Safety of Rituximab in Hepatitis B Virus-Associated PLA2R-Positive Membranous Nephropathy

Kidney Int Rep. 2017 Sep 21;3(2):486-491. doi: 10.1016/j.ekir.2017.09.009. eCollection 2018 Mar.

Lena Berchtold^{1

2

3}, Gilbert Zanetta⁴, Karine Dahan⁵, Fabrice Mihout⁵, Julie Peltier⁶, Dominique Guerrot⁷, Isabelle Brochériou⁸, Pierre Ronco^{1

2

5}, Hanna Debiec^{1

2}

¹ Inserm, UMR_S 1155, Paris, France.
² Sorbonne Universités, Université Pierre et Marie Curie University of Paris 06, Paris, France.
³ Department of Internal Medicine, Service of Internal Medicine, Geneva University Hospital, Geneva, Switzerland (current address).
⁴ Department of Nephrology, Dijon University Hospital, Dijon, France.
⁵ Department of Nephrology and Dialysis, Assistance Publique-Hôpitaux de Paris, Tenon Hospital, Paris, France.
⁶ Department of Renal Intensive Care Unit and Kidney Transplantation, AP-HP, Tenon Hospital, Paris, France.
⁷ Department of Nephrology, Rouen University Hospital, Normandie University, Université de Rouen, Inserm U1096, Rouen, France.
⁸ Department of Pathology, Assistance Publique-Hôpitaux de Paris, Tenon Hospital, Paris, France.

No abstract available

Publication types